C12Y 301/01084
Cocaine esterase
Official title: Cocaine esterase (3.1.1.84)
C12Y301/01084 (Cocaine esterase) appears on 11 US grants and 15 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 15
- Assignees
- 9
- Inventors
- 37
- Latest grant
- 31 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 1 | 0 |
| 2013 | 2 | 2 |
| 2014 | 1 | 2 |
| 2015 | 1 | 0 |
| 2016 | 1 | 3 |
| 2017 | 0 | 1 |
| 2018 | 2 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Cocaine esterase mutant and use thereof31 Dec 2024US 12,180,519 B2Hangzhou Normal University
- Mutants of cocaine esterase24 Aug 2021US 11,098,296 B2The Trustees of Columbia University in the City of New York
- Mutants of cocaine esterase25 Dec 2018US 10,160,960 B2The Trustees of Columbia University in the City of New York
- High activity mutants of cocaine esterase for cocaine hydrolysis30 Jan 2018US 9,879,240 B2University of Kentucky Research Foundation
- Thermostabilization of proteins27 Dec 2016US 9,526,786 B2The Regents of the University of Michigan
- Compositions, methods, and articles comprising cocaine esterase for detoxifying an organophosphate-based agent10 Apr 2025US 2025/0114653 A1Four Winds Biotherapeutics, Inc.
- Cocaine esterase mutant and use thereof11 Apr 2024US 2024/0117329 A1Hangzhou Normal University
- Mutants of cocaine esterase21 Nov 2019US 2019/0352625 A1The Trustees of Columbia University in the City of New York
- Thermostabilization of proteins20 Apr 2017US 2017/0106056 A1The Regents of the University of Michigan
- Mutants of cocaine esterase23 Jun 2016US 2016/0177277 A1The Trustees of Columbia University in the City of New York
Most cited
By later US patents
- Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use15US 7,049,121 B2Applied Molecular Evolution, Inc. · 2006
- Anti-cocaine compositions and treatment7US 8,318,156 B2The Regents of the University of Michigan · 2012
- BChE albumin fusions for the treatment of cocaine abuse1US 8,541,373 B2Teva Pharmaceutical Industries Ltd. · 2013
- Thermostabilization of proteins1US 8,637,009 B2The Regents of the University of Michigan · 2014
- Anti-cocaine compositions and treatment1US 9,200,265 B2The Regents of the University of Michigan · 2015